Tag: influenza
In a first, Zydus Lifesciences to launch vaccine against new strain...
Quadrivalent Inactivated Influenza vaccine - VaxiFlu - 4 to offer seasonal protection against 4 new virus strains
Vaccination can drastically reduce lung-related illnesses in India, say doctors at...
Ahead of World Lung Day, doctors emphasize the role of adult vaccination in reducing respiratory infections and easing hospital burdens
HCMCT Manipal Hospital partners with Pfizer to launch adult vaccination centre...
The Centre aims to enhance protection against vaccine-preventable diseases, focusing on adult vaccination in high-risk populations
Apollo Clinic rolls out nationwide campaign across 102 locations to combat...
The campaign offers targeted vaccinations and tests aiming to reduce monsoon-related diseases like dengue, malaria, and influenza
Pfizer and Amrita Hospital launch Centre of Excellence for adult vaccination...
The initiative aims to boost community protection against vaccine-preventable diseases with enhanced adult vaccination efforts
Cadila Pharma introduces Quadrivalent Influenza Vaccine in India
Vaccine targets four strains of the Influenza virus subtype–A and B, responsible for seasonal epidemics
Nasovac-S4 offers defence against recent surge in respiratory illnesses, say experts
NASOVAC-S4, India’s first exclusive needle-free flu vaccine, is administered through the nasal route, offering a non-invasive and painless alternative to traditional injections
Pfizer initiates Phase 3 Study of mRNA-based Influenza vaccine
First Phase 3 efficacy study to be conducted using an mRNA-based influenza vaccine; study will enroll 25,000 U.S. adults 18 years and older
Vaccination only key to prevent influenza infections amongst at-risk adults: Experts
Annual influenza vaccination is the most safe and effective strategy to avoid infection, reducing risk of flu-related complications by 70 to 90 percent
Moderna kickstarts Phase 1/2 study for influenza vaccine candidate
Both mRNA-1020 and mRNA-1030 target hemagglutinin and neuraminidase antigens, two major influenza surface glycoproteins that are essential across the viral life cycle